Journal Home
Search for

Volume 19, Issue 9, Pages 654-658 (September 2009)


View previous. 8 of 14 View next.

Association between corneal temperature and mental status of treatment-resistant schizophrenia inpatients

Roni ShilohaCorresponding Author Informationemail address, Lior Schapira, Danit Bar-Zivb, Rafael Stryjerc, Shai Konasa, Rachel Louisa, Haggai Hermesha, Hanan Munitza, Abraham Weizmana, Avi Valevskia

Received 9 November 2008; received in revised form 12 April 2009; accepted 28 April 2009. published online 04 June 2009.

Abstract 

Introduction

Preliminary point-prevalent data suggest that drug-free schizophrenia patients may exhibit increased body/corneal temperature, that antipsychotic drugs (APDs) may decrease body/core temperature and that patients' mental status might be associated with their body/corneal temperature. Hence, we hypothesized that treatment-resistant psychotic APD-treated schizophrenia patients' mental status may correlate with their corneal temperature during a continuous 6-week period.

Methods

Corneal temperature of 12 treatment-resistant schizophrenia inpatients and 16 healthy volunteers was evaluated 2–3 times a week during 6 consecutive weeks using a flir thermal imaging camera.

Results

A significant and substantial correlation was found between inpatients' mean weekly Positive and Negative Syndrome Scale (PANSS)'s total scores and their mean weekly corneal temperature during the 6-week study period (r=0.82; n=6 weeks; p=0.043). There was no significant difference in mean 6-week corneal temperature between the patient group and the healthy subjects (34.25±0.64 °C vs. 34.39±0.69 °C, respectively; t=1.127, df=131, p=0.26).

Conclusions

This study indicates that treatment-resistant overtly psychotic schizophrenia inpatients' mental status (as assessed by the PANSS) correlates with their corneal temperature. The relevance of these phenomena to the pathophysiology of schizophrenia, the biological mechanism underlying corneal temperature alterations and the possible role of temperature-modulating drugs (neuroleptics or non-neuroleptics) on schizophrenic psychosis merits further large-scale investigation in both medicated- and drug-free schizophrenia patients compared to matched controls.

a Geha Mental Health Center, Felsenstein Medical Research Center, Rabin Medical Center, Beilinson Campus, Petach-Tikva, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

b Tel-Aviv Community Mental Health Center, Tel-Aviv, Israel

c Beer-Yaakov Mental Health Center, Beer-Yaakov, Israel

Corresponding Author InformationCorresponding author. Geha Mental Health Center, PO Box 102, Petach-Tikva 49100, Israel. Tel.: +972 3 9258284; fax: +972 3 9258421.

PII: S0924-977X(09)00119-9

doi:10.1016/j.euroneuro.2009.04.010


View previous. 8 of 14 View next.